Company Filing History:
Years Active: 2008
Title: Mitsuko Okazaki: Innovator in Lipoprotein Regulation
Introduction
Mitsuko Okazaki is a prominent inventor based in Sakado, Japan. She has made significant contributions to the field of health and nutrition through her innovative research. Her work focuses on the regulation of serum remnant-like lipoprotein concentrations, which is crucial for maintaining cardiovascular health.
Latest Patents
Mitsuko Okazaki holds 1 patent for her invention titled "Serum remnant-like lipoprotein concentration regulator." This invention discloses serum remnant-like lipoprotein concentration regulators that contain triglycerides of medium-chain fatty acids. The formulation specifies that 90% or more by weight of the fatty acids are saturated fatty acids with 8 and 10 carbon atoms. The weight ratio between these saturated fatty acids is maintained between 60/40 to 85/15. Additionally, the proportion of saturated fatty acids with 8 carbon atoms in all fatty acids bonding to the second position of the triglyceride is between 60 to 85% by weight. The invention also includes foods and pharmaceutical compositions designed to control the concentration of serum remnant-like lipoproteins, which can be used easily without concerns about side effects or restrictive diets.
Career Highlights
Mitsuko Okazaki is associated with the Nisshin Oillio Group, Ltd., where she continues to advance her research in lipoprotein regulation. Her work has garnered attention for its potential impact on public health and nutrition.
Collaborations
Mitsuko has collaborated with notable colleagues, including Hideaki Maki and Michio Kasai, to further her research and development efforts in this field.
Conclusion
Mitsuko Okazaki's innovative work in serum remnant-like lipoprotein concentration regulation highlights her significant contributions to health and nutrition. Her patent reflects a commitment to improving dietary options and pharmaceutical solutions for better health outcomes.